Flude, B.M., et al. (2021) Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus Infections. Viruses, 13, 312.
https://doi.org/10.3390/v13020312

has been cited by the following article:

• TITLE: COVID-19 Pulmonary and Extrapulmonary Complications

  AUTHORS: Linling Li, Ruitao Zhang, Fang Li, Chufan Xiao, Bowen Zhong, Shiyao Zhai, Changyue Liu, Qiuyue Hu, Juan Lyu, Ming Yang, Chengming Yang, Li Lyu, Yan Li, Dongmei Yu

  KEYWORDS: COVID-19, SARS-CoV-2, Complications, Manifestations

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.10 No.3, March 14, 2022

  ABSTRACT: To date, the coronavirus disease 2019 (COVID-19) outbreak has become a global pandemic and public health disaster. In addition to acute respiratory manifestations, patients with COVID-19 exhibit other non-respiratory manifestations, particularly in those with severe underlying disease. Few specific therapeutics are effective for COVID-19, and supportive care is the primary remedy. Here, we comprehensively surveyed the most recent reports on extrapulmonary complications of COVID-19 and their corresponding treatments, as well as the comparison of different clinical symptoms and complications of COVID-19, severe acute respiratory syndrome (SARS), and the Middle East respiratory syndrome (MERS) patients. We wish to provide a molecular and cellular understanding of the complications of COVID-19 and provide guidance for future diagnostics, therapeutics, and prognostics of COVID-19.